From biology to the clinic — exploring liver metastasis in prostate cancer

Ni, Xudong; Wei, Yu; Li, Xiaomeng; Pan, Jian; Fang, Bangwei; Zhang, Tingwei; Lu, Ying; Ye, Dingwei; Zhu, Yao

doi:10.1038/s41585-024-00875-x

Nat Rev Urol

2024

DOI: 10.1038/s41585-024-00875-x

|View full text |Cite

From biology to the clinic — exploring liver metastasis in prostate cancer

Xudong Ni,

Yu Wei,

Xiaomeng Li

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 233 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Recent advances in basic research on prostate cancer: Where we are heading?

Obinata,

Yamada,

Sumiyoshi

et al. 2024

Int J of Urology

View full text Add to dashboard Cite

In the over 80 years since androgens were found to play a pivotal role in prostate cancer (PCa) progression, androgen deprivation therapy (ADT) has been a cornerstone in treating advanced PCa. Castration‐resistant PCa persists, however, with some of these tumors evolving to androgen receptor (AR)‐independent forms like neuroendocrine PCa. The development of novel diagnostic and therapeutic approaches to PCa is therefore crucial. This review provides an overview of recent basic research in PCa, focusing on two main areas: PCa cells and their tumor microenvironments. The first section describes current knowledge on the intricate mechanisms of AR signaling pathways, emphasizing the roles of coactivators and chromatin state alterations in gene regulation. Genomic analyses have revealed recurrent mutations and copy number alterations critical for precision medicine. Liquid biopsy has become a promising tool for real‐time tumor monitoring, identifying genetic alterations in circulating‐tumor DNA or extracellular vesicles. The second section describes the tumor microenvironment of PCa, highlighting its immunosuppressive landscape and the potential of combining ADT with immunotherapy. Advanced techniques, including single‐cell RNA sequencing and spatial transcriptomics offer insights into cellular heterogeneity and interactions within the tumor microenvironment, paving the way for novel therapeutic strategies. Integration of these diverse research areas will provide a comprehensive understanding of the current state and future directions of PCa research, underscoring the importance of personalized medicine and the dynamic nature of cancer treatment strategies.

show abstract

Recent advances in basic research on prostate cancer: Where we are heading?

Obinata,

Yamada,

Sumiyoshi

et al. 2024

Int J of Urology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

From biology to the clinic — exploring liver metastasis in prostate cancer

Cited by 1 publication

References 233 publications

Recent advances in basic research on prostate cancer: Where we are heading?

Recent advances in basic research on prostate cancer: Where we are heading?

Contact Info

Product

Resources

About